Diffuse Large B-Cell Lymphoma, NOS · None
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.
| Track | standard |
|---|---|
| Linked regimen | None |
| ID | IND-IATROGENIC-METHOTREXATE-LONGTERM-LYMPHOMA-PREVENTION-SURVEILLANCE |
|---|---|
| Type | Indication |
| Status | reviewed 2026-05-19 | pending_clinical_signoff |
| Diseases | DIS-DLBCL-NOS |
| Sources | SRC-NCCN-BCELL-2025 |
Notes
STUB — v0.3 iatrogenic prevention expansion. Two-Co-Lead signoff queued per CHARTER §6.1 dev-mode.
Used By
No reverse references found in the YAML corpus.